“What does take a long time... Negotiations, organizing and planning arrangements, looking at other indications (CHF), talking to regulatory bodies (FDA, NIH), future trial design... amending contract.”
”amending contract”. SI recenty made specific comment that the contract is staying as is? Had me scratching my head as well?
The reference to CHF discussions seems like a smoke screen to me? As CHF is further away as another P3 is definitely required?
Stalling whilst keeping everyone on the edge of their seats?
Madness or genius?
MSB Price at posting:
$2.19 Sentiment: Hold Disclosure: Held
(20min delay)